Versican isoforms modulate expression and function of nicotinic acetylcholine receptors

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 1, Issue 1, 2009, Pages 64-75

  Wu, Yaojiong ^a,b   Sheng, Wang ^a,b   Dong, Haiheng ^a,c   Lapierre, David ^a,b   Wan, Yudi ^a,c   Lu, Wei Yang ^a,c,d   Yang, Burton B ^a,b,d  

^a Sunnybrook Health Sciences Centre   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Differentiation; Neurite outgrowth; PC12 cells; Phosphorylation

Indexed keywords

MONOCLONAL ANTIBODY; NICOTINIC RECEPTOR; PROTEIN SUBUNIT; VERSICAN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSFECTION; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 77953381410     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Shinomura T, Nishida Y, Ito K, Kimata K: cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican. J Biol Chem 1993;268:14461-14469.
2. Paulus W, Baur I, Dours-Zimmermann MT, Zimmermann DR: Differential expression of versican isoforms in brain tumors. J Neuropathol Exp Neurol 1996;55:528-533.
3. Wu YJ, La Pierre DP, Wu J, Yee AJ, Yang BB: The interaction of versican with its binding partners. Cell Res 2005;15:483-494.
4. Zimmermann DR, Ruoslahti E: Multiple domains of the large fibroblast proteoglycan, versican. Embo J 1989;8:2975-2981.
5. Yang BL, Cao L, Kiani C, Lee V, Zhang Y, Adams ME, Yang BB: Tandem repeats are involved in G1 domain inhibition of versican expression and secretion and the G3 domain enhances glycosaminoglycan modification and product secretion via the complement-binding protein-like motif. J Biol Chem 2000;275:21255-21261.
6. Lemire JM, Braun KR, Maurel P, Kaplan ED, Schwartz SM, Wight TN: Versican/PG-M isoforms in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999;19:1630-1639.
7. Ito K, Shinomura T, Zako M, Ujita M, Kimata K: Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol Chem 1995;270:958-965.
8. Oohira A, Matsui F, Tokita Y, Yamauchi S, Aono S: Molecular interactions of neural chondroitin sulfate proteoglycans in the brain development. Arch Biochem Biophys 2000;374:24-34.
9. Bandtlow CE, Zimmermann DR: Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 2000;80:1267-1290.
10. Landolt RM, Vaughan L, Winterhalter KH, Zimmermann DR: Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 1995;121:2303-2312.
11. Schmalfeldt M, Dours-Zimmermann MT, Winterhalter KH, Zimmermann DR: Versican V2 is a major extracellular matrix component of the mature bovine brain. J Biol Chem 1998;273:15758-15764.
12. Lemire JM, Merrilees MJ, Braun KR, Wight TN: Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. J Cell Physiol 2002;190:38-45.
13. Zhang Y, Cao L, Kiani CG, Yang BL, Yang BB: The G3 domain of versican inhibits mesenchymal chondrogenesis via the epidermal growth factor-like motifs. J Biol Chem 1998;273:33054-33063.
14. Zhang Y, Cao L, Yang BL, Yang BB: The G3domain of versican enhances cell proliferation via epidermial growth factor-like motifs. J Biol Chem 1998;273:21342-21351.
15. Wu Y, Zhang Y, Cao L, Chen L, Lee V, Zheng PS, Kiani C, Adams ME, Ang LC, Paiwand F, Yang BB: Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding. J Biol Chem 2001;276:14178-14186.
16. Zheng PS, Wen J, Ang LC, Sheng W, Viloria-Petit A, Wang Y, Wu Y, Kerbel RS, Yang BB: Versican/PG-M G3 domain promotes tumor growth and angiogenesis. Faseb J 2004;18:754-756.
17. Ang LC, Zhang Y, Cao L, Yang BL, Young B, Kiani C, Lee V, Allan K, Yang BB: Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain. J Neuropathol Exp Neurol 1999;58:597-605.
18. Yee AJ, Akens M, Yang BL, Finkelstein J, Zheng PS, Deng Z, Yang B: The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Breast Cancer Res 2007;9:R47.
19. Marshall V, Parks T, Bagni R, Wang CD, Samols MA, Hu J, Wyvil KM, Aleman K, Little RF, Yarchoan R, Renne R, Whitby D: Conservation of virally encoded microRNAs in Kaposi sarcoma-associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. J Infect Dis 2007;195:645-659.
20. Vaudry D, Stork PJ, Lazarovici P, Eiden LE: Signaling pathways for PC12 cell differentiation: making the right connections. Science 2002;296:1648-1649.
21. Traverse S, Seedorf K, Paterson H, Marshall CJ, Cohen P, Ullrich A: EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol 1994;4:694-701.
22. Whiting PJ, Schoepfer R, Swanson LW, Simmons DM, Lindstrom JM: Functional acetylcholine receptor in PC12 cells reacts with a monoclonal antibody to brain nicotinic receptors. Nature 1987;327:515-518.
23. LaPierre DP, Lee DY, Li SZ, Xie YZ, Zhong L, Sheng W, Deng Z, Yang BB: The ability of versican to simultaneously cause apoptotic resistance and sensitivity. Cancer Res 2007;67:4742-4750.
24. Wang CH, Lee DY, Deng Z, Jeyapalan Z, Lee SC, Kahai S, Lu WY, Zhang Y, Yang BB: MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS ONE 2008;3:e2420.
25. Lee DY, Deng Z, Wang CH, Yang BB: MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci U S A 2007;104:20350-20355.
26. Sheng W, Dong H, Lee DY, Lu WY, Yang BB: Versican modulates gap junction intercellular communication. J Cell Physiol 2007;211:213-219.
27. Sheng W, Wang G, Wang Y, Liang J, Wen J, Zheng PS, Wu Y, Lee V, Slingerland J, Dumont D, Yang BB: The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol Biol Cell 2005;16:1330-1340.
28. Sheng W, Wang G, La Pierre DP, Wen J, Deng Z, Wong CK, Lee DY, Yang BB: Versican mediates mesenchymal-epithelial transition. Mol Biol Cell 2006;17:2009-2020.
29. Wu Y, Sheng W, Chen L, Dong H, Lee V, Lu F, Wong CS, Lu WY, Yang BB: Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth. Mol Biol Cell 2004;15:2093-2104.
30. Xiang YY, Dong H, Wan Y, Li J, Yee A, Yang BB, Lu WY: Versican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptor. J Biol Chem 2006;281:19358- 19368.
31. Binette F, McQuaid DP, Haudenschild DR, Yaeger PC, McPherson JM, Tubo R: Expression of a stable articular cartilage phenotype without evidence of hypertrophy by adult human articular chondrocytes in vitro. J Orthop Res 1998;16:207-216.
32. Matsuoka I, Mizuno N, Kurihara K: Cholinergic differentiation of clonal rat pheochromocytoma cells (PC12) induced by retinoic acid: increase of choline acetyltransferase activity and decrease of tyrosine hydroxylase activity. Brain Res 1989;502:53-60.
33. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY: Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996;85:707-720.
34. Zhang J, El-Mas MM, Abdel-Rahman AA: Imidazoline I(1) receptor-induced activation of phosphatidylcholine-specific phospholipase C elicits mitogen-activated protein kinase phosphorylation in PC12 cells. Eur J Pharmacol 2001;415:117-125.
35. Foehr ED, Bohuslav J, Chen LF, DeNoronha C, Geleziunas R, Lin X, O'Mahony A, Greene WC: The NF-kappa B-inducing kinase induces PC12 cell differentiation and prevents apoptosis. J Biol Chem 2000;275:34021-34024.
36. Milev P, Maurel P, Chiba A, Mevissen M, Popp S, Yamaguchi Y, Margolis RK, Margolis RU: Differential regulation of expression of hyaluronan-binding proteoglycans in developing brain: aggrecan, versican, neurocan, and brevican. Biochem Biophys Res Commun 1998;247:207-212.
37. Cooper E, Couturier S, Ballivet M: Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 1991;350:235-238.
38. Marutle A, Warpman U, Bogdanovic N, Lannfelt L, Nordberg A: Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation. J Neurochem 1999;72:1161-1169.
39. McGehee DS: Molecular diversity of neuronal nicotinic acetylcholine receptors. Ann N Y Acad Sci 1999;868:565-577.
40. Sudweeks SN, Yakel JL: Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. J Physiol 2000;527 Pt 3:515-528.
41. Jones L: Revealing micro-RNAs in plants. Trends Plant Sci 2002;7:473-475.
42. Rogers SW, Mandelzys A, Deneris ES, Cooper E, Heinemann S: The expression of nicotinic acetylcholine receptors by PC12 cells treated with NGF. J Neurosci 1992;12:4611-4623.
43. Sands SB, Barish ME: Calcium permeability of neuronal nicotinic acetylcholine receptor channels in PC12 cells. Brain Res 1991;560:38-42.
44. Utsugisawa K, Nagane Y, Obara D, Tohgi H: Over-expression of alpha7 nicotinic acetylcholine receptor induces sustained ERK phosphorylation and N-cadherin expression in PC12 cells. Brain Res Mol Brain Res 2002;106:88-93.
45. Chan J, Quik M: A role for the nicotinic alphabungarotoxin receptor in neurite outgrowth in PC12 cells. Neuroscience 1993;56:441-451.